Protocol Ledger

NCT06059495 · Phase II · RECRUITING

DEWI: Watch-and-Wait With Dostarlimab in Localized dMMR/MSI-H Gastric/GEJ Adenocarcinoma Phase II Study

Interventional Phase II clinical trial protocol NCT06059495 sponsored by GERCOR - Multidisciplinary Oncology Cooperative Group in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2024-01-22 Enrollment: 89 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06059495
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)89 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06059495
Protocol FieldVerified Registry Value
NCT IdentifierNCT06059495
Consolidated Lead SponsorGERCOR - Multidisciplinary Oncology Cooperative Group
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment89 participants (ESTIMATED)
Registered Start Date2024-01-22
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT06059495
Hospital Research SiteLocationSite Profile
Centre Leon BerardLyon, FranceOpen Hospital Dossier ->
Institut Paoli-CalmettesMarseille, FranceOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI